The expression of FoxP3 (%) was significantly downregulated in HIV-positive NHL patients on ART (HIV-positive NHL) as compared to both HIV-negative NHL (NHL) patients (Mean ± s.d.: 4.28 ± 1.87 vs. 6.37 ± 2.04; p < 0.0001) and ART-treated HIV-positive patients (HIV-positive ART) (Mean ± s.d.: 4.28 ± 1.87 vs. 5.02 ± 0.91; p = 0.0171) (Figure 2). The gene discussed is FOXP3; the disease is non-Hodgkin lymphoma.